Advisory Services Network’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-54
Closed -$859 3039
2026
Q1
$859 Buy
+54
New +$1.17K ﹤0.01% 4346
2025
Q4
Sell
-222
Closed -$5.02K 2672
2025
Q3
$5.02K Buy
+222
New +$4.57K ﹤0.01% 3538
2024
Q2
Sell
-39,500
Closed -$857K 1566
2024
Q1
$857K Sell
39,500
-1,077
-3% -$26.7K 0.02% 749
2023
Q4
$1.17M Sell
40,577
-311
-0.8% -$8.32K 0.03% 581
2023
Q3
$1.09M Buy
40,888
+677
+2% +$23.1K 0.03% 603
2023
Q2
$1.49M Sell
40,211
-518
-1% -$18.1K 0.04% 507
2023
Q1
$1.27M Sell
40,729
-72
-0.2% -$2.32K 0.04% 541
2022
Q4
$1.22M Buy
40,801
+5,455
+15% +$195K 0.04% 530
2022
Q3
$1.35M Sell
35,346
-1,674
-5% -$83.9K 0.05% 449
2022
Q2
$2.02M Sell
37,020
-2,057
-5% -$113K 0.07% 343
2022
Q1
$2.44M Sell
39,077
-876
-2% -$57.7K 0.07% 342
2021
Q4
$4.02M Buy
39,953
+1,304
+3% +$115K 0.12% 218
2021
Q3
$3.48M Sell
38,649
-1,255
-3% -$114K 0.11% 236
2021
Q2
$3.68M Buy
39,904
+2,654
+7% +$212K 0.12% 225
2021
Q1
$3.6M Buy
37,250
+17,366
+87% +$1.79M 0.13% 195
2020
Q4
$1.04M Buy
+19,884
New +$831K 0.04% 485

Other funds holding FLGT

Advisory Services Network's FLGT Position: Q2 2026 in Review

Advisory Services Network sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 54 shares — an estimated $859 sold.

Advisory Services Network first reported a position in FLGT in Q4 2020 and held it in 16 quarters. The position peaked at $4.02M in Q4 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Advisory Services Network reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 54 Fulgent Genetics shares in Q2 2026, an estimated $859.
  • Advisory Services Network first reported a position in Fulgent Genetics in Q4 2020 and held it in 16 quarters.
  • Advisory Services Network's Fulgent Genetics position peaked at $4.02M in Q4 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.